1. Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment. (1st October 2021) Authors: Chawana, Tariro D.; Nhachi, Charles F. B.; Nathoo, Kusum; Ngara, Bernard; Okochi, Hideaki; Louie, Alexander; Kuncze, Karen; Katzenstein, David; Metcalfe, John; Gandhi, Monica Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 2(2021) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment. (1st October 2021) Authors: Chawana, Tariro D.; Nhachi, Charles F. B.; Nathoo, Kusum; Ngara, Bernard; Okochi, Hideaki; Louie, Alexander; Kuncze, Karen; Katzenstein, David; Metcalfe, John; Gandhi, Monica Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 2(2021) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment. (1st October 2021) Authors: Chawana, Tariro D.; Nhachi, Charles F. B.; Nathoo, Kusum; Ngara, Bernard; Okochi, Hideaki; Louie, Alexander; Kuncze, Karen; Katzenstein, David; Metcalfe, John; Gandhi, Monica Journal: Journal of acquired immune deficiency syndromes Issue: Volume 88:Number 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Capacity building and predictors of success for HIV‐1 drug resistance testing in the Asia‐Pacific region and Africa. Issue 1 (10th July 2013) Authors: Land, Sally; Zhou, Julian; Cunningham, Philip; Sohn, Annette H; Singtoroj, Thida; Katzenstein, David; Mann, Marita; Sayer, David; Kantor, Rami Journal: Journal of the International AIDS Society Issue: Volume 16:Issue 1(2013) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment. (1st September 2017) Authors: Chawana, Tariro D.; Gandhi, Monica; Nathoo, Kusum; Ngara, Bernard; Louie, Alexander; Horng, Howard; Katzenstein, David; Metcalfe, John; Nhachi, Charles F. B. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 76:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Drug resistance and optimizing dolutegravir regimens for adolescents and young adults failing antiretroviral therapy. (1st September 2019) Authors: Kouamou, Vinie; Manasa, Justen; Katzenstein, David; McGregor, Alan M.; Ndhlovu, Chiratidzo E.; Makadzange, Azure T. Journal: AIDS Issue: Volume 33:Number 11(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Early Virologic Response to Abacavir/Lamivudine and Tenofovir/Emtricitabine During ACTG A5202. Issue 6 (November 2013) Authors: Grant, Philip M.; Tierney, Camlin; Budhathoki, Chakra; Daar, Eric S.; Sax, Paul E.; Collier, Ann C.; Fischl, Margaret A.; Zolopa, Andrew R.; Balamane, Maya; Katzenstein, David Journal: HIV clinical trials Issue: Volume 14:Issue 6(2013) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. HIV diversity and drug resistance from plasma and non‐plasma analytes in a large treatment programme in western Kenya. Issue 2 (18th November 2014) Authors: Kantor, Rami; DeLong, Allison; Balamane, Maya; Schreier, Leeann; Lloyd, Robert M; Injera, Wilfred; Kamle, Lydia; Mambo, Fidelis; Muyonga, Sarah; Katzenstein, David; Hogan, Joseph; Buziba, Nathan; Diero, Lameck Journal: Journal of the International AIDS Society Issue: Volume 17:Issue 2 (2014)Supplement 1 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in Zimbabwe. (2nd February 2018) Authors: Chimbetete, Cleophas; Katzenstein, David; Shamu, Tinei; Spoerri, Adrian; Estill, Janne; Egger, Matthias; Keiser, Olivia Journal: Open forum infectious diseases Issue: Volume 5:Number 2(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Human Immunodeficiency Virus-1 Sequence Changes and Drug Resistance Mutation Among Virologic Failures of Lopinavir/Ritonavir Monotherapy: AIDS Clinical Trials Group Protocol A5230. (24th August 2016) Authors: Vardhanabhuti, Saran; Katzenstein, David; Bartlett, John; Kumarasamy, Nagalingeswaran; Wallis, Carole L. Journal: Open forum infectious diseases Issue: Volume 3:Number 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗